Suppliers / Zhejiang Candorly Pharmaceutical

Zhejiang Candorly Pharmaceutical

China Updated 9 July 2026

Zhejiang Candorly Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Taiping, Wenling City, China Not on file

What they file, and where

Molecule Regulators Docs
Clindamycin US FDA 1
Tenofovir Disoproxil US FDA 1

Also appears on these molecule pages

Questions about Zhejiang Candorly Pharmaceutical

Does Zhejiang Candorly Pharmaceutical hold a US DMF or a CEP?
Zhejiang Candorly Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Zhejiang Candorly Pharmaceutical manufacture?
1 registered site is on record, in China (Taiping, Wenling City). Every site is listed on this page with the register it came from.
What does Zhejiang Candorly Pharmaceutical make?
2 molecules are on record against Zhejiang Candorly Pharmaceutical, including Clindamycin and Tenofovir Disoproxil. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Candorly Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability